Drug Profile


Alternative Names: Coactinon; I-EBU; MKC 442

Latest Information Update: 03 Mar 2003

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Mitsubishi Chemical
  • Class Antiretrovirals; Pyrimidinones; Small molecules
  • Mechanism of Action RNA-directed DNA polymerase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Brain cancer
  • Discontinued HIV-1 infections

Most Recent Events

  • 03 Mar 2003 No development reported - Phase-II for Brain cancer in USA (PO)
  • 24 Jan 2002 Discontinued-III for HIV-1 infections in European Union (PO)
  • 24 Jan 2002 Discontinued-III for HIV-1 infections in Mexico (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top